Introduction
============

Exfoliation glaucoma (XFG) is an age-related disorder associated with exfoliation syndrome (XFS), manifested by abnormal fibrillar deposits on the lens and iris epithelium \[[@r1]\]. Recently, a genome wide association study performed for the Caucasian population revealed a strong association between the genotype of single genetic polymorphisms (SNPs) in the *lysyl oxidase-like 1* (*LOXL1*) gene and the occurrence of XFS/XFG \[[@r2]\]. It was reported that the rate of XFG occurrence significantly differed from one ethnic population to another \[[@r3]\], therefore it is logically important to perform a case-control study using another ethnic population such as the Japanese. In this study, we found a strong genetic association between the occurrence of XFG and the *LOXL1* single nucleotide polymorphism (SNP) genotype. One of the nonsynonymous SNP ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)) showed a very strong association with XFG. However, the risk allele was inverse compared to the Caucasian study. To gain further insight into the role of *LOXL1* for XFG, it is important to compare the expression levels of *LOXL1* mRNA in XFG eyes and non-glaucomatous eyes. We obtained anterior lens capsules during combined glaucoma-cataract surgery or during cataract surgery alone from XFG patients and non-glaucomatous senile cataract patients, respectively. We then performed a quantitative analysis of *LOXL1* mRNA expression using these anterior lens capsules.

Methods
=======

Subjects
--------

All XFG patients were diagnosed by slit-lamp examination for the existence of exfoliation material on the anterior lens capsule with maximal dilation of the pupils and with glaucomatous optic neuropathy as well as visual field defect. Peripheral blood was obtained from 95 XFG patients 47--93 years of age (mean age: 75.7±8.1 years). The controls were 190 randomly-selected, population-based individuals 54--83 years of age (mean age: 65.0±6.8 years) with no glaucomatous changes or existence of exfoliation materials ([Table 1](#t1){ref-type="table"}). All of the XFG patients and normal volunteers were recruited at Kyoto Prefectural University Hospital (Kyoto, Japan) and examined by glaucoma specialists using slit-lamp microscopy and an automated visual field analyzer. All study subjects were ethnically Japanese. According to the rules of the process committee at Kyoto Prefectural University of Medicine, written informed consent was obtained from all participants before participation in this genetic association study. The study was conducted in accordance with the tenets of the Declaration of Helsinki.

###### Clinical characters of the exfoliation glaucoma patients and control.

  -------------------------- --------------------- ---------------------
                             **XFG**               **Control**
  Total number of subjects   95                    190
  Mean age (range)           75.7 (47--93 years)   65.0 (54--83 years)
  -------------------------- --------------------- ---------------------

Ninety-five exfoliation glaucoma patients 47 to 93 years of age (mean age: 75.7 years), and 190 randomly-selected population-based individuals 54 to 83 years of age (mean age: 65.0 years) with no glaucomatous changes or existence of exfoliation materials were involved in this study.

Genotyping
----------

We genotyped two nonsynonymous single nucleotide polymorphisms (SNPs; [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)) in the *LOXL1* gene region according to the previous report \[[@r2]\]. We genotyped the SNPs with both direct sequencing and the TaqMan genotyping assay (Applied Biosystems, Foster City, CA). We used a set of primers (5′-GAT CCA GTG GGA GAA CAA CG-3′ and 5′-GGT ACT CGG GCA GCT CTT C-3′) for direct sequencing. Genotyping was performed using on a 3130xl Sequence Detection System or with 7500 Realtime-time polymerase chain reaction (PCR) system (Applied Biosystems). The TaqMan genotyping assay was performed according to the manufacturer's protocol. All the genotyping procedures were approved by the ethics committee of Kyoto Prefectural University of Medicine.

Statistical analysis
--------------------

The frequencies of the genotypes were compared between XFG patients and controls in the recessive model. In this model, frequencies of the homozygous genotype for major alleles were compared using a 2x2 contingency table. Here, the association was evaluated using the χ^2^ test for the contingency table. A p-value of less than 0.01 was considered to be statistically significant. Odds ratios (OR) and 95% confidence intervals (95% CI) were also calculated.

Real-time polymerase chain reaction analysis
--------------------------------------------

Anterior capsules that were obtained during glaucoma/cataract or cataract surgery with written informed consent were immediately stored with RNAlater reagent (Ambion, Austin, TX) to protect the RNA. All procedures were approved by the ethics committee of Kyoto Prefectural University of Medicine. Total RNA was isolated with the Micro RNA extraction kit (Qiagen Japan, Tokyo, Japan) from the anterior capsules, and then cDNA was prepared as described previously \[[@r4]\]. The anterior capsules were obtained from 10 XFG patients undergoing combined (cataract+glaucoma) surgery (mean age 74.9±8.0 years; male:female=6:4) and 10 non-glaucomatous, senile cataract patients (mean age: 76.5±10.6 years; male:female=4:6). To avoid contamination of blood, anterior lens capsulotomy was performed before glaucoma surgery in cases of combined procedures. We used TaqMan real-time PCR probes and primers specific for human *LOXL1* (Hs00173746_m1), and 18S rRNA from Applied Biosystems (Assay-on-Demand gene expression products). Real-time PCR analysis was performed on a 7500 real-time PCR system. The relative expression of *LOXL1* mRNA in the anterior lens capsule was quantified by the standard curve method using 18S rRNA expression in the same cDNA as the control.

Results
=======

Case-control association study in the *LOXL1* gene region
---------------------------------------------------------

We genotyped 95 XFG cases and 190 control subjects by direct sequencing methods. The [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) TT genotype and the [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) GG genotype in the first exon of *LOXL1* were significantly associated with an increased risk of XFG under recessive models (χ^2^ test, raw p value=5.34x10^−34^, OR=321.3, 95% CI=43.5--2373.2 and p=2.1x10^−8^, OR=38.3, 95% CI=5.2--281.6, respectively; [Table 2](#t2){ref-type="table"}). We further tested reproducibility of the genotyping by TaqMan genotyping assay and confirmed the genotyping results because the results of the [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) genotyping was not concordant with the Hardy--Weinberg equilibrium (HWE). The results obtained by the two methods were identical.

###### Case-control study of two nonsynonymous single nucleotide polymorphisms in *LOXL1*.

  ------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------- --------- -------------- ------------- ---------
  [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)  **(R141L)\***   [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)  **(G153D)\*\***                                          
  **Genotype**                                                                         **Control**                                                                            **XFG**   **Genotype**   **Control**   **XFG**
  GG                                                                                   33                                                                                     0         GG             135           94
  GT                                                                                   114                                                                                    1         GA             53            1
  TT                                                                                   43                                                                                     94        AA             2             0
  ------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------- --------- -------------- ------------- ---------

The [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) TT genotype and the [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) GG genotype were significantly associated with an increased risk of XFG under recessive models (χ^2^ test). The single asterisk indicates TT versus GT+GG, P value=5.34x10--34, OR=321.3, and 95% CI=43.5--2373.2, and the double asterisk indicates GG versus GA+AA, p=2.1x10--8, OR=38.3, and 95% CI=5.2--281.6.

Haplotype analysis of *LOXL1* single nucleotide polymorphisms
-------------------------------------------------------------

First, we checked the state of linkage disequilibrium (LD) between [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) and found that those two SNPs are in a state of strong LD ([Table 3](#t3){ref-type="table"}). Next, we examined the distribution of two-locus haplotypes in the XFG and control samples ([Table 4](#t4){ref-type="table"}) using [Haploview](http://www.broad.mit.edu/mpg/haploview/) \[[@r5]\] and PENHAPLO \[[@r6]\] software. Among the two-locus haplotypes of SNPs in exon 1 ([rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G/T and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) G/A), the TG haplotype showed an increased risk for XFG (TG/TG versus others; p=6.87x10^−7^, OR=312.162) in recessive models. We checked HWE among control subjects using this two-locus haplotype and found that the two-locus haplotype was concordant with HWE (p=0.0125, χ^2^ test).

###### Linkage disequilibrium state of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942).

  -------------- --------- --------
  **SNP**        **D\'**   **r2**
  Control+XFG    1         0.243
  Control only   1         0.196
  XFG only       1         1
  -------------- --------- --------

We calculated the state of linkage disequilibrium between [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) among the control population, XFG population, and total population. Linkage disequilibrium coefficients were expressed as D\' or r2.

###### Structures and frequency of two locus haplotype.

  --------------- --------------- --------
  **Haplotype**   **Frequency**   
  **Case**        **Control**     
  TG              0.9947          0.5263
  GG              0               0.3237
  GA              0.0053          0.15
  --------------- --------------- --------

We examined the frequency of two-locus haplotypes in the XFG and control samples using [Haploview](http://www.broad.mit.edu/mpg/haploview/) and PENHAPLO software. The TG haplotype means [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)-T and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)-G, the GG haplotype means [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)-G and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)-G, and the GA haplotype means [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)-G and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942)-A.

*LOXL1* mRNA quantification using anterior lens capsules
--------------------------------------------------------

cDNA was synthesized from total RNA isolated from the anterior lens capsules of patients undergoing cataract surgery. We analyzed both XFG (n=10) and senile cataract (n=10) specimens. [Figure 1](#f1){ref-type="fig"} is a representative result of two independent results of experiments run in duplicate. There was no statistically significant difference between the expression levels of *LOXL1* mRNA in the lens epithelium obtained from XFG patients and senile cataract patients. ([Figure 1](#f1){ref-type="fig"}, p=0.529 by the Mann--Whitney U*-*test)

![Real-time polymerase chain reaction analysis of *LOXL1* mRNA expression in anterior lens capsules. Total RNA was extracted from the anterior lens capsule of XFG/senile cataracts. Real-time PCR analysis was performed with expression assay probes. The amount of relative expression was normalized to that of 18Sr RNA. (N.S.: Not statistically significant, p=0.529; Mann--Whitney's U-test).](mv-v14-1037-f1){#f1}

Discussion
==========

Similar to previous studies among Caucasian \[[@r2],[@r7],[@r8]\], we found a strong genetic association between the *LOXL1* SNP and XFG patients. The lysyl oxidase protein family has multiple functions including specific oxidative deamination of lysine residues and the cross-linking of elastin \[[@r9]\]. Phenotypic analysis of *LOXL1* knockout mice \[[@r10]\] showed that the LOXL1 protein has an essential role for the homeostasis of elastic fibers, which also contribute to the trabecular meshwork structures \[[@r11]\]. Therefore, it is functionally reasonable to assume that *LOXL1* is one of the causative genes for XFG.

For the [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) genotype, our results are consistent with those of Thorleifsson et al. \[[@r2]\]. The allele frequency of [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) G is consistently higher among Caucasian and Japanese XFG patients so it is reasonable to conclude that [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) A is a protective allele against the occurrence of XFG.

On the other hand, the risk allele for XFG occurrence is [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)-"T" among the Japanese population and [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)-"G" among the Caucasian population. We double-checked these genotype results ([rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942) and [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661)) by both direct sequencing and the TaqMan genotyping assay because the genotype results of [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) within control subjects were not concordant with HWE. The results obtained from two different methods were in complete agreement. Therefore non-concordance with HWE is not due to genotyping errors. We further checked the two-locus haplotype and found that the haplotype was concordant with HWE. Since the two-locus, [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and [rs3825942](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3825942), was in the state of linkage disequilibrium (D'=1.0), it was appropriate to check the HWE by haplotype.

Inverted genotypes of XFG patients between the Japanese and Caucasian population suggests the following possibilities: (1) The 141st amino acid substitution (R141L) does not have a dominant role for the pathophysiology of XFG, (2) the heterozygote for the [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G/T genotype may have a protective role against XFG occurrence, or (3) there might be another causative polymorphism in a state of linkage disequilibrium with [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G/T. If the last possibility is the case, there might be a historical recombination between the SNP [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) and the causative polymorphism.

As a next step, we quantified relative *LOXL1* mRNA expression in anterior lens capsules and found that there was no significant difference between XFG and senile cataract controls. These results are different from the previous study by Thorleifsson et al. \[[@r2]\], which showed a significantly higher *LOXL1* mRNA expression with the TT genotype (the protective genotype against XFG in the Caucasian population) than those with the TG or GG genotype using adipose tissues. We hypothesize that the difference might be due to the mixed *LOXL1* SNP genotype of our senile cataract surgery samples, which are not able to clarify genotype due to ethical procedure reasons. However, our *LOXL1* mRNA expression analysis reflects a direct pathological site within the ocular tissue and better represents *LOXL1* expression status in the affected eyes than that of adipose tissue \[[@r2]\]. Therefore, we deduced that it is likely that the quantitative difference of *LOXL1* mRNA is not a direct pathogenetic cause of XFG.

To further clarify the pathophysiological role of *LOXL1* for XFG, we are now performing extensive SNP discovery around *LOXL1* to find out other possible causative polymorphisms. In addition, functional analysis of LOXL1-fibulin5 protein interaction \[[@r12]\] using two types of recombinant LOXL1 precursor protein (141R and 141L) is ongoing. Since LOXL1-fibulin5 interaction is essential for mature cross-linked elastin formation \[[@r10],[@r12]\], we are focused on determining the role of the two variants of *LOXL1* and its mixture to gain further insight into our genetic association results showing that the [rs1048661](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048661) G/T heterozygote is protective against XFG. It is also important to investigate the protective role of LOXL1 protein variants that possess the 153D amino acid, which is indicated by multiple genetic association studies including our own \[[@r2],[@r7],[@r8]\] as well as to analyze the possible role of the pairs of 141/153 amino acid variants in consideration of our haplotype analysis result.
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